ARCHIVES

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

An Early Look At How NCI Plans To Spend Its Money In 1980

July 7, 1978

California To Help Uninsured Get Prostate Cancer Therapy.

July 13, 2001

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

Funding Opportunities: Department of Defense Ovarian Cancer Research

May 5, 2000

Comments Invited On Centers Program

November 27, 1987

Scientists, advocates voice objections to von Eschenbach’s conflicts, 2015.

November 23, 2005